Dexcom share price logo

Dexcom

NASDAQ: DXCM

Large Cap

$89.35

+1.42

(+1.61%)

as on

Dexcom Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $87.54
    $89.92
    downward going graph

    2.03%

    Downside

    0.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $54.11
    $92.59
    downward going graph

    39.44%

    Downside

    3.63%

    Upside

    downward going graph

Dexcom share price movements today

Previous Close
$87.93
Open
$87.80
Volume
4.0M
Market Cap
$33.2B
Day's Low - High
$87.54 - $89.92
52 Week Low - High
$54.11 - $92.59

Dexcom Historical Returns

1 Month Return
-2.17 %
3 Month Return
+ 21.33 %
1 Year Return
+ 30.36 %
3 Year Return
-6.62 %
5 Year Return
-37.54 %

Dexcom Stock Fundamentals & Key Indicators

Check Dexcom market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$33.2B

EPS (TTM)

2.59

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

33.95

Industry PE ratio

23.26

PEG Ratio

0.44559121621621645

EBITDA

1.6B

Revenue (TTM)

5.0B

Profit Margin

62.47%

Return On Equity TTM

36.19%

Dexcom Stock Valuation

Track how Dexcom P/E has moved over time to understand its valuation trends.

Dexcom in the last 5 years

  • Overview

  • Trends

Lowest (31.01x)

December 31, 2025

Industry (23.26x)

December 31, 2025

Today (31.01x)

December 31, 2025

Highest (239.45x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 31.01x

Dexcom vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dexcom with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$33.2B-37.54%33.9562.47%0.00%
BUY$50.9B-26.1%50.7277.98%0.00%
BUY$119.9B-28.47%22.6866.69%3.08%
BUY$176.6B-19.37%32.8156.80%2.42%
BUY$108.0B2.6%28.7965.17%1.22%

Stock Returns calculator for Dexcom Stock including INR - Dollar returns

The Dexcom stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dexcom investment value today

Current value as on today

₹1,44,167

Returns

₹44,167

(+44.17%)

Returns from Dexcom Stock

₹32,468 (+32.47%)

Dollar Impact

₹11,698 (+11.7%)

Analyst Recommendation on Dexcom Stock

Based on 19 analysts

BUY

94.74%

Buy

5.26%

Hold

0.00%

Sell

Based on 19 analysts, 94.73684210526315% of analysts recommend a 'BUY' rating for Dexcom. Average target price of $94.48

Dexcom Share Price Target

Get share price movements and forecasts by analysts on Dexcom.

What analysts predicted

5.43%UPSIDE

Target Price

$94.48

Current Price

$89.35

Analyzed by

19 Analysts

Target

$94.48

Dexcom target price $94.48, a slight upside of 5.43% compared to current price of $89.35. According to 19 analysts rating.

Indian Investors' Interest in Dexcom Stock

Search interest for Dexcom Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Dexcom Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
921
1,004
994
1,113
1,036
1,157
1,209
1,259
1,191
1,308
Gross Profit
561
626
593
655
589
688
731
792
750
830
Operating Income
101
158
152
188
133
212
242
323
255
318
EBITDA
189
244
237
274
219
308
420
410
339
388
Interest Expense
4
4
4
4
4
4
4
4
3
3
Depreciation
52
52
55
57
60
63
63
65
67
68
Income Before Tax
132
187
177
211
154
241
352
340
269
317
Income Tax Expense
-13
44
42
59
48
61
68
73
70
68
Net Income
146
143
134
151
105
179
283
267
199
249
Net Profit Margin
61.01%
62.40%
59.73%
58.90%
56.85%
59.53%
60.48%
62.93%
62.95%
63.44%

Dexcom Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
718
1,031
1,476
1,926
2,448
2,909
3,622
4,033
4,662
Gross Profit
492
663
931
1,280
1,680
1,883
2,288
2,438
2,801
Operating Income
-42
-186
142
299
265
391
597
600
911
EBITDA
-19
-74
213
376
377
565
916
945
1,358
Interest Expense
12
22
60
84
18
18
20
19
18
Depreciation
16
29
48
67
101
155
186
217
251
Income Before Tax
-48
-126
104
225
256
390
710
709
1,088
Income Tax Expense
1
0
3
-268
39
49
168
132
252
Net Income
-50
-127
101
493
216
341
541
576
836
Net Profit Margin
68.49%
64.36%
63.11%
66.44%
68.63%
64.72%
63.19%
60.46%
60.10%

Dexcom Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
146
143
134
151
105
179
283
267
199
249
Operating Cash Flow
209
279
199
301
183
303
659
294
525
269
Investing Cash Flow
74
-188
210
-303
100
-63
192
306
-298
329
Financing Cash Flow
4
-1
-736
-1
12
-1
-175
-1,522
-25
-607
Change in Cash
284
88
-316
-15
298
254
676
-917
199
-13

Dexcom Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-127
101
493
154
341
541
576
836
Operating Cash Flow
92
123
314
475
442
669
748
989
1,440
Investing Cash Flow
-144
-139
-1,015
-1,018
-216
-521
-507
-207
536
Financing Cash Flow
399
710
10
912
10
-552
-318
-734
-1,686
Change in Cash
347
695
-690
371
235
-410
-75
39
311

Mutual Funds that own Dexcom Stock

Check out the Mutual Funds with significant holdings in Dexcom.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
10.214716%
38546335
Fidelity Concord Street Trust
1.81772%
6859364
VANGUARD SPECIALIZED FUNDS
1.686762%
6365180
Fidelity Salem Street Trust
1.02218%
3857309
BlackRock Funds
0.942348%
3556055

Global Institutional Holdings in Dexcom

Funds
Holdings
Vanguard
11.44%
iShares
6.95%
Invesco
4.85%
SPDR
4.08%
Amundi
1.42%

Dexcom News & Key Events

  • img

    Today's Timeline - 15 September

    Tue, 07:23 PM

    -

    Dexcom director Nicholas Augustinos plans to sell 6,539 shares under Rule 144, valued at $549,537.56.

    Wed, 01:32 AM

    -

    Dexcom officer Michael Brown plans to sell 1,700 shares, with an aggregate market value of $142,868.

Insights on Dexcom

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 199.50M → 249.09M (in $), with an average increase of 19.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.19B → 1.30B (in $), with an average increase of 8.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DXCM stock has moved up by 7.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DXCM has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 20.9% return, outperforming this stock by 26.0%

About Dexcom

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
OrganisationDexcom
Headquarters6340 Sequence Drive, San Diego, CA, 92121, US
IndustryMedical - Devices
CEOJacob Steven Leach
E-voting on sharesClick here to vote

Key Management of Dexcom

Name

Title

Mr. Kevin Ronald Sayer

Executive Chairman of the Board

Mr. Michael Jon Brown J.D.

Executive VP, Chief Legal & Compliance Officer

Mr. Peter Simpson

Executive VP & CTO

Mr. Sean Christensen

Vice President of Finance and Investor Relations

Mr. Matthew Dolan

Executive Vice President of Strategy & Corporate Development

Keri Leone

Senior Director of Global Medical Science & Education

Christine Pospisil

Director of Medical Science & Education

Mr. Jacob Steven Leach

President, CEO & Director

Ms. Sadie M. Stern

Executive VP, Chief People & Culture Officer

Mr. Jon Coleman

Executive VP & Chief Commercial Officer

FAQs

What is Dexcom share price today?

Dexcom share price today is $89.35 as on at the close of the market. Dexcom share today touched a day high of $89.92 and a low of $87.54.

What is the 52 week high and 52 week low for Dexcom share?

Dexcom share touched a 52 week high of $92.59 on and a 52 week low of $54.11 on . Dexcom stock price today i.e. is closed at $89.35,which is 3.50% down from its 52 week high and 65.13% up from its 52 week low.

What is Dexcom's market capitalisation today?

Dexcom market capitalisation is $0.03T as on .

How to invest in Dexcom Stock (DXCM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dexcom on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dexcom Shares that will get you 0.0168 shares as per Dexcom share price of $89.35 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Dexcom Stock (DXCM) from India?

Indian investors can start investing in Dexcom (DXCM) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Dexcom stock (as per the Rupee-Dollar exchange rate as on ). Based on Dexcom share’s latest price of $89.35 as on September 19, 2026 at 8:45 am IST, you will get 0.1119 shares of Dexcom. Learn more about fractional shares .

What are the returns that Dexcom has given to Indian investors in the last 5 years?

Dexcom stock has given -37.54% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?